22 jun: Glitter og glamour i overhalingsbanen - Monaco grandprix 2012 set..
26 jun: Den hurtigste Bentley til dato - Continental GT Speed
25-06-2012 22:09:00

US Capital-Equipment Loans, Leases Up 10.7% In May - Survey

Relateret indhold
Relateret debat
05 dec - 
En af de dyreste - men også sundeste banker i US. Synes..
05 dec - 
Har købt BAC i går. Fortryder det faktisk lidt. :-( Er ..

--Equipment leasing and finance activity increased 10.7% in May from year earlier

--Loans and leases past due were unchanged from April

--Approval rate for loans and leases was 78% in May

By Bob Tita

A survey of credit providers showed that loans and leases for business equipment in the U.S. increased 10.7% in May from a year earlier, but capital spending volume was nearly unchanged from April.

Respondents to the Equipment Leasing and Finance Association's monthly survey said they financed $6.2 billion of new equipment last month, up from $5.6 billion in the year-earlier period. May's volume was up 1.6% from April, suggesting that spending is moderating in the face of weakening U.S. economic growth, lower prices for commodities and the sovereign debt crisis in Europe. Nevertheless, since the beginning of 2012, spending is up 15.9% from a year ago at $29.2 billion.

Spending on equipment has been expanding faster than the broader U.S. economy as companies replace worn-out or obsolete equipment after deferring such activity during the 2008 recession and the sluggish recovery.

"Although overall spending has steadily increased since the financial crisis, pockets of the market are still tenuous, said Maureen Carr, managing director of the corporate asset finance group for CapitalSource. "Some customers are cancelling or postponing purchases amidst softer commodity prices or weaker demand from abroad."

Credit portfolio quality measured by the survey improved slightly from a year earlier and was mostly stable on a month-to-month basis. Loans and leases past due by more than 30 days fell to 2.7% of survey respondents' net receivables in May, from 2.9% a year earlier and unchanged from April.

Charge-offs amounted to 0.5% of respondents' net receivables last month, down from 0.8% a year earlier and down from 0.6% in April. The approval rate for loans and leases was 78.3% in May, compared with 76.4% a year earlier and 76.4% in April. Survey respondents continued to cite construction and trucking as the industry sectors within their loan portfolios that are underperforming.

A monthly confidence index of the U.S. capital-equipment finance industry fell to 48.5 in June from 59.2 in May.

The 25 respondents to the association's survey included banks Wells Fargo & Co. (WFC), Bank of America Corp. (BAC) and Fifth Third Bancorp (FITB), as well as finance units for manufacturers Caterpillar Inc. (CAT), Deere & Co. (DE), Volvo Group and Dell Inc. (DELL).

Write to Bob Tita at robert.tita@dowjones.com

(END) Dow Jones Newswires

June 25, 2012 16:09 ET (20:09 GMT)

Copyright (c) 2012 Dow Jones & Company, Inc.

Opret kommentar

Relateret debat

  • 1 uge
  • 1 måned
  • 1 År
Ingen indlæg

Fondsbørsmeddelelser

Harboes H1: Dårligt sommervejr ramte både omsætningen og indtjeningen

13-12-2017 15:48:19
Dårligt sommervejr i Nordeuropa ramte både omsætningen og indtjeningen hos Harboes Bryggeri, der har haft et markant dårligere første halvår af det skæve regnskabsår 2017/18 sammenlignet med for et år siden.Nettoomsætningen fra maj til udgangen af oktober faldt til 696,4 mio. kr. mod 744,6 mio. kr. i samme periode året forinden, fremgår det af halvårsregnskabet for 2017/18 onsdag eftermiddag.På de..

Novo-rival spår effekt af ugentligt GLP-1 på linje med Ozempics

13-12-2017 13:30:09
Novo Nordisks store franske rival Sanofi forudser, at dens ugentlige GLP-1-analog, Efpeglenatid, har en effekt på langtidsblodsukkeret, der er på linje Novos nye ugentlige diabetes 2-middel Ozempic, som tilhører samme lægemiddelklasse.Det fremgår af en præsentation under et analytikerarrangement onsdag, hvor Sanofi fremlægger sin forsknings- og udviklingsstrategi for de kommende år.Sanofi indledte..

Novo-rival er på vej med nye studier i fedme og leversygdommen NASH

13-12-2017 09:56:25
Novo Nordisks store franske rival, Sanofi, vil ligesom Novo i de kommende år også fokusere på udviklingen af fedmemedicin og medicin til behandling af leversygdommen, NASH.Det fremgår af en pressemeddelelse i forbindelse med et analytikerarrangement onsdag, hvor Sanofi vil præsentere sin forsknings- og udviklingsstrategi for de kommende år.Sanofis udviklingsindsats inden for forretningsområdet, di..

Mest læste nyheder

  • 24 timer
  • 48 timer
  • 1 uge
1
Vestas får sin største ordre nogensinde i Indien - NY
2
Vestas rykker nærmere kæmpekontrakter i New Mexico og Texas
3
Onsdagens aktier: Genmab endnu engang til bunds i negativt marked
4
Aktier: C20 og kompagni lagt ned i timevis af teknisk uheld - NY4
5
Nilfisk: Storaktionær opfordrer til fusion med konkurrent - NY2

Relaterede aktiekurser

Bank of America Corporat.. 28,84 0,0% Aktiekurs uændret
Caterpillar Inc 148,57 0,0% Aktiekurs uændret
Deere & Company 151,95 0,0% Aktiekurs uændret
Wells Fargo & Company 59,40 0,0% Aktiekurs uændret
Fifth Third Bancorp 29,94 0,0% Aktiekurs uændret
Caterpillar Inc 132,53 0,0% Aktiekurs uændret

Køb- og salgsanbefalinger

  • Trend
  • Pengemaskinen

Copyright Euroinvestor A/S 2017  Disclaimer Privatlivspolitik
Aktieinformation leveres af Morningstar.
Data er forsinket 15-20 minutter iht. de enkelte børsers regler om videredistribution.
 
14. december 2017 09:05:38
(UTC+01:00) Brussels, Copenhagen, Madrid, Paris
Version: LiveBranchBuild_20171124.1 - EUROWEB7 - 2017-12-14 09:05:38 - 2017-12-14 09:05:38 - 1 - Website: OKAY